Prevention Of Chronic Renal Failure Post Transplantation | 39100
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

2nd International Conference on Biotechnology and Healthcare

Auckland, New Zealand

6th International Conference on Vaccines and Immunology

Geneva, Switzerland

3rd European Congress on Virology

Geneva, Switzerland
Google scholar citation report
Citations : 1600

Journal of Biotechnology & Biomaterials received 1600 citations as per google scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Prevention of chronic renal failure post transplantation

6th World Congress on Biotechnology

Chirag Mohan Sharma

Amity University, India

Posters-Accepted Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.C1.044

Organ transplantation and its techniques have encountered a great deal of improvement and development in last 50 years after the first renal transplant which took place in 1950 in United States of America on Ruth tucker a 44 years women. Organ transplant have become safer and lesser risky due to several advancements in the surgical and medicinal fields. Renal transplant is one of the major organ transplant which accounts for around 12,000 transplants all over the world. Despite of these enhancements still there are failures and lives are lost due to low graft survival in the long run which is termed as chronic renal failure. This is also affected by lifestyle issues but mainly immunological and non immunological aspects like medication used, blood pressure, donor age, senescence and aging of the cells, late antibody response etc. Generally the age of the transplant and the patient is 8-12 years after the transplant takes place but the number of years that the patient lives can be increased and the life expectancy rate can be enhanced by the application of medication including Tacrolimus and cyclosporine and rapamycin etc and keeping a check on after transplant complications like increase in protein urea, development of antibodies in renal cells which can be detected by processes like ELISPOT etc. This way a longer and better life can be given to patients who have given so much in combating the disease.

Chirag Mohan Sharma is currently pursuing BSc in Medical Biotechnology from Amity Institute of Biotechnology, Amity University, India. He has an utter curiosity in the field of human physiology and response of human body to different drugs and he aspires to pursue masters in the same field.

Email: [email protected]